Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485518 | PMC |
http://dx.doi.org/10.4212/cjhp.v68i3.1463 | DOI Listing |
Thromb Res
January 2025
Department of Pharmacy, Jewish General Hospital, McGill University, Montreal, Canada. Electronic address:
Background: Anticoagulants have consistently emerged as the leading cause of adverse drug events in both inpatient and outpatient settings. While literature on anticoagulation stewardship programs (ACSP) exists for hospital settings, there is a paucity of data in long-term care and rehabilitation settings.
Objective: Assess the feasibility of a pharmacist led ACSP in the ambulatory healthcare settings of long-term care facilities (LTC) and rehabilitation centers (RC).
Can J Hosp Pharm
November 2024
BPharm, MSc, MBA, FCSHP, is the Executive Director of the Association des pharmaciens des établissements de santé du Québec (A.P.E.S.), Montréal, Quebec.
Background: In the face of province-wide implementation of activity-based hospital funding in Quebec, a need arose to effectively measure pharmacists' contributions along the patient care trajectory and to enable pharmacy benchmarking using valid performance indicators.
Objectives: A 3-phase project was initiated to measure the performance and impact of pharmacists and pharmacy departments. Phases 2 and 3, described here, focused on gradually implementing, in various health care centres, the priority indicators selected in phase 1.
Trials
October 2024
Univ Angers, POPS, SFR ICAT, Angers, F-49000, France.
Background: Urinary tract infections are common affections, especially for women. Difficult access to a general practitioner to obtain a prescription has led France to offer dispensing under protocol by community pharmacists. The primary objective of this study is to evaluate the effectiveness of a pharmacist care protocol provided to manage women with urinary tract infection symptoms.
View Article and Find Full Text PDFCan J Hosp Pharm
September 2024
, B. Pharm., M. Sc., Pharm. D., F.C.S.H.P., F.O.P.Q., est pharmacienne au département d'obstétrique et de gynécologie du CHU Sainte-Justine et professeure titulaire de clinique et directrice du programme PharmD à la Faculté de pharmacie de l'Université de Montréal, Montréal (Québec). Elle est également rédactrice adjointe du Journal canadien de la pharmacie hospitalière.
Therapie
November 2024
Nantes Université, CHU de Nantes, Centre d'Évaluation et d'Information sur la Pharmacodépendance-Addictovigilance (CEIP-A), Service de Pharmacologie Clinique, 44000 Nantes, France; Nantes Université, Université Tours, CHU Nantes, CHU Tours, Inserm, MethodS in Patients-centered outcomes and HEalth Research, SPHERE, 44000 Nantes, France. Electronic address:
Objective: For several years, both the French Addictovigilance Network and French health authorities have consistently emphasized the need to provide opioid users with take-home naloxone (THN), the specific antidote for opioid overdoses. In March 2022, the French Health Authority recommended systematically assessing the appropriateness of prescribing THN to all opioid users, regardless of the context, and identified 8 high-risk situations. However, at present, THN distribution remains limited, particularly among primary care healthcare professionals.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!